Sartorius AG Postpones Sale of Industrial Weighing Division

Sartorius, a leading international laboratory and pharmaceutical equipment provider, postponed the planned divestiture of its Industrial Weighing Division for the time being. While this division has attracted the wide interest of a number of investors, their investment decisions are being impacted by the current uncertain economic environment. “Interest in this business is significant, but obtaining a selling price that reflects the value of the division is not possible at present,” explained CEO Joachim Kreuzburg. “However, this will not alter our long-term plans for our industrial weighing business.”

At the beginning of 2012, Sartorius decided to concentrate on its core laboratory and bioprocess businesses and to divest the smallest of its three divisions over the medium term. The Industrial Weighing Division reported sales revenue of 102.7 million euros and an underlying EBITDA margin of 11.6% for fiscal 2012.

This press release contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties. This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

Upcoming Financial Dates
June 23, 2013 Publication of the first-half figures for 2013
October 21, 2013 Publication of the nine-month figures for 2013

A Profile of Sartorius

The Sartorius Group is a leading international laboratory and process technology provider covering the segments of Bioprocess Solutions, Lab Products & Services and Industrial Weighing. In 2012, the technology group earned sales revenue of 845.7 million euros. Founded in 1870, the Goettingen-based company currently employs around 5,500 persons. The major areas of activity of its Bioprocess Solutions segment cover filtration, fluid management, fermentation, cell cultivation and purification, and focus on production processes in the biopharmaceutical industry. The Lab Products & Services segment primarily manufactures laboratory instruments and consumables. Industrial Weighing concentrates on weighing, monitoring and control applications in the manufacturing processes of the food, chemical and pharma sectors. Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.

Contact:
Sartorius Corporate Administration GmbH
Petra Kirchhoff, Vice President of Corporate Communications and IR
Phone: +49 (0)551/ 308-1686
fax: +49 (0)551/ 308-3572
E-mail: petra.kirchhoff@sartorius.com
www.sartorius.com

Help employers find you! Check out all the jobs and post your resume.

Back to news